Bausch Health Companies (BHC) Prepaid Assets (2009 - 2026)
Bausch Health Companies (BHC) reported Prepaid Assets of $874.0 million for Q1 2026, down 1.8% on a YoY basis from $890.0 million in Q1 2025, and up 2.58% sequentially from $852.0 million in Q4 2025.
Bausch Health Companies (BHC) Prepaid Assets (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Prepaid Assets data on file, last reported at $874.0 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 1.8% year-over-year to $874.0 million; the trailing twelve-month figure through Mar 2026 stood at $874.0 million (down 1.8% YoY), and the FY2025 full-year result was $852.0 million, up 1.67% from the prior year.
- Prepaid Assets grew to $874.0 million in Q1 2026, from $852.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.1 billion in Q4 2023 to a low of $718.0 million in Q3 2022.
- A 5-year average of $873.1 million and a median of $874.0 million in 2024 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets surged 45.96% in 2023 and retreated 23.26% in 2024, its largest moves.
- Tracing BHC's Prepaid Assets over 5 years: stood at $776.0 million in 2022, then surged by 40.72% to $1.1 billion in 2023, then declined by 23.26% to $838.0 million in 2024, then advanced by 1.67% to $852.0 million in 2025, then rose by 2.58% to $874.0 million in 2026.
- Business Quant data shows BHC's Prepaid Assets at $874.0 million in Q1 2026, $852.0 million in Q4 2025, and $894.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 874.00 Mn |
| Dec 31, 2025 | 852.00 Mn |
| Sep 30, 2025 | 894.00 Mn |
| Jun 30, 2025 | 906.00 Mn |
| Mar 31, 2025 | 890.00 Mn |
| Dec 31, 2024 | 838.00 Mn |
| Sep 30, 2024 | 852.00 Mn |
| Jun 30, 2024 | 874.00 Mn |
| Mar 31, 2024 | 957.00 Mn |
| Dec 31, 2023 | 1.09 Bn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 890.00 Mn |
| Mar 31, 2023 | 796.00 Mn |
| Dec 31, 2022 | 776.00 Mn |
| Sep 30, 2022 | 718.00 Mn |
| Jun 30, 2022 | 820.00 Mn |
| Mar 31, 2022 | 765.00 Mn |
| Dec 31, 2021 | 720.00 Mn |
| Sep 30, 2021 | 632.00 Mn |
| Jun 30, 2021 | 899.00 Mn |